Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 136 member A (FAM136A) is a gene that encodes a highly conserved, mitochondrially localized protein of currently unclear function. It is broadly expressed in human tissues and is particularly notable in the neurosensory epithelium of the crista ampullaris (inner ear). Mutations in FAM136A, including nonsense and missense variants, have been linked to familial Meniere's disease—a chronic inner ear disorder characterized by episodic vertigo, tinnitus, and hearing loss. Expression changes have also been reported in extraocular muscles in ophthalmoplegic myasthenia gravis, and somatic mutations or altered expression have been found in several cancers, such as lung carcinoma and oral tongue squamous cell carcinoma in never-smokers. The protein is presumed to contribute to mitochondrial integrity and cellular homeostasis in sensory and perhaps muscular tissues, but its precise molecular and biological roles remain to be defined through further functional studies.
None described, as FAM136A is not a validated drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 136 member A (FAM136A).